Carcinoma ex pleomorphic adenoma of the parotid gland. Study and implications for diagnostics and therapy
Authors:
- Jan-Christoffer LüersJLJan-Christoffer Lüers
- Claus WittekindtCWClaus Wittekindt
- M. StreppelMSM. Streppel
- Orlando Guntinas-LichiusOrlando Guntinas-Lichius
- 1 January 2009
- journal article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 48 (1) , 132-136
Abstract
Carcinoma ex pleomorphic adenoma (CXPA) is a rare parotid malignancy and until today no standardized concept exists for its therapy apart from recommendations for parotid carcinoma in general. Prognosis is thought to be poorer than for other parotid malignancies. We sought to describe a general diagnostic and therapy strategy and assess factors predicting the outcome. We retrospectively analysed the courses of 22 patients with a CXPA of the parotid gland treated at a tertiary medical care centre for otorhinolaryngology. We examined parameters of medical history, diagnostics, surgical and adjunctive therapy and analysed overall and disease-specific survival. About half of the patients had evidence of a parotid mass of up to 1 year only while maximum of the others was 48 years. Nine patients were primarily operated without suspicion for malignancy. Both 5-year disease-specific and overall survival were 60%. Recurrence-free survival rate after 5 years was 85%. Any patients with a stage I or II disease had an uneventful follow-up. To date, no patient with a stage IV disease has survived longer than 5 years. Surgical therapy (total or radical parotidectomy) is the method of choice for CXPA of the parotid gland. Stage I tumors have a very good and stage IV tumors a bad prognosis.Keywords
This publication has 10 references indexed in Scilit:
- The role of postoperative radiation therapy in carcinoma ex pleomorphic adenoma of the parotid glandInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Carcinoma Ex Benign Pleomorphic Adenoma of the Parotid GlandPlastic and Reconstructive Surgery, 2005
- Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progressionHistopathology, 2005
- Carcinoma ex pleomorphic adenoma: A clinicopathologic reviewHead & Neck, 2001
- Carcinoma ex pleomorphic adenoma: Pathologic analysis of 73 casesHuman Pathology, 2001
- SALIVARY GLAND DISORDERSMedical Clinics of North America, 1999
- Problematik der Diagnostik und Therapie des Karzinoms im stromareichen pleomorphen Adenom der Glandula parotisMund-,Kiefer- und Gesichtschirurgie, 1998
- Karzinome in vorbestehenden Warthin-Tumoren (Zystadenolymphomen) der ParotisDer Pathologe, 1997
- Recurrent Mixed TumorAnnals of Otology, Rhinology & Laryngology, 1986
- The Management of Salivary Neoplasms an OverviewAuris Nasus Larynx, 1985